Literature DB >> 15947946

Thyroid transcription factor 1 expression in cystic lesions of the neck: an immunohistochemical investigation of thyroglossal duct cysts, branchial cleft cysts and metastatic papillary thyroid cancer.

Andreas Kreft1, Torsten Hansen, Charles James Kirkpatrick.   

Abstract

Cervical metastases of papillary thyroid cancer (PTC) are of particular diagnostic importance, because they can mimic branchiogenic cysts clinically and histopathologically when undergoing cystic change. Immunohistochemical stains for thyroid transcription factor 1 (TTF-1), which are positive in thyroid cancers, are reported to be valuable in establishing diagnosis. However, TTF-1 may also be expressed in dysontogenetic cysts of the neck. Therefore, immunohistochemical stains for TTF-1 and thyroglobulin (TG) were performed on each of the ten thyroglossal duct cysts, branchial cleft cyst and lymph node metastasis of PTC. Five in ten cases of thyroglossal duct cysts were positive for TTF-1, but all were negative for TG. One of the ten branchial cleft cysts stained for TTF-1, while all cases were negative for TG. All ten cases of lymph node metastases of PTC showed positive for TTF-1, nine of which were positive for TG. Since a positive immunostaining for TTF-1 in cystic lesions of the neck was not only found in metastases of PTC, but also in non-malignant branchiogenic cysts, additional investigations, e.g. an immunostaining for TG, should be added in difficult cases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15947946     DOI: 10.1007/s00428-005-1227-1

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  13 in total

1.  Pathologic quiz case: cystic lesion in the neck of a 51-year-old woman.

Authors:  M P Fernandez; S Ismail; J Y Ro
Journal:  Arch Pathol Lab Med       Date:  2001-06       Impact factor: 5.534

2.  Expression of thyroid transcription factor-1 (TTF-1) in human C cells and medullary thyroid carcinomas.

Authors:  R Katoh; E Miyagi; N Nakamura; X Li; K Suzuki; K Kakudo; M Kobayashi; A Kawaoi
Journal:  Hum Pathol       Date:  2000-03       Impact factor: 3.466

3.  Thyroid transcription factor-1, thyroglobulin, cytokeratin 7, and cytokeratin 20 in thyroid neoplasms.

Authors:  P A Bejarano; Y E Nikiforov; E S Swenson; P W Biddinger
Journal:  Appl Immunohistochem Mol Morphol       Date:  2000-09

Review 4.  Thyroid transcription factor-1 is a marker of lung and thyroid carcinomas.

Authors:  N G Ordóñez
Journal:  Adv Anat Pathol       Date:  2000-03       Impact factor: 3.875

5.  Immunostaining for thyroid transcription factor 1 and cytokeratin 20 aids the distinction of small cell carcinoma from Merkel cell carcinoma, but not pulmonary from extrapulmonary small cell carcinomas.

Authors:  W Cheuk; M Y Kwan; S Suster; J K Chan
Journal:  Arch Pathol Lab Med       Date:  2001-02       Impact factor: 5.534

6.  TTF-1 expression is specific for lung primary in typical and atypical carcinoids: TTF-1-positive carcinoids are predominantly in peripheral location.

Authors:  Emma Z Du; P Goldstraw; Jo Zacharias; Olivier Tiffet; Paul J Craig; Andrew G Nicholson; Noel Weidner; Eunhee S Yi
Journal:  Hum Pathol       Date:  2004-07       Impact factor: 3.466

7.  Expression of thyroid transcription factor 1 in primary brain tumours.

Authors:  J Zamecnik; M Chanova; R Kodet
Journal:  J Clin Pathol       Date:  2004-10       Impact factor: 3.411

8.  Thyroid transcription factor-1 expression in the human neonatal tracheoesophageal fistula.

Authors:  Troy L Spilde; Amina M Bhatia; Kelly A Miller; Daniel J Ostlie; Beverly E Chaignaud; George W Holcomb; Charles L Snyder; George K Gittes
Journal:  J Pediatr Surg       Date:  2002-07       Impact factor: 2.545

9.  The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain.

Authors:  D Lazzaro; M Price; M de Felice; R Di Lauro
Journal:  Development       Date:  1991-12       Impact factor: 6.868

10.  Utility of thyroid transcription factor-1 and cytokeratin 20 in identifying the origin of metastatic carcinomas of cervical lymph nodes.

Authors:  Mee Sook Roh; Sook Hee Hong
Journal:  J Korean Med Sci       Date:  2002-08       Impact factor: 2.153

View more
  7 in total

1.  Thyroid transcription factor 1 (TTF-1) and p63 expression in two primary thyroid papillary carcinomas of branchial cleft cysts.

Authors:  S Lanzafame; R Caltabiano; L Puzzo; A Cappellani
Journal:  Virchows Arch       Date:  2006-04-21       Impact factor: 4.064

2.  Primary papillary carcinoma originated from a branchial cleft cyst.

Authors:  Jin Seong Cho; Sun Hyoung Shin; Hee Kyung Kim; Ji Shin Lee; Min Ho Park; Jung Han Yoon; Young Jong Jegal
Journal:  J Korean Surg Soc       Date:  2011-11-25

3.  The relationship between the location of thyroglossal duct cysts and the epithelial lining.

Authors:  Aiman A Ali; Badr Al-Jandan; C S Suresh; Ahmad Subaei
Journal:  Head Neck Pathol       Date:  2012-09-12

4.  Papillary Thyroid Carcinoma Cervical Lymph Node Metastasis with Cystic Change Differentiated from Congenital Cystic Lesions with the Assistance of Immunohistochemistry: A Case Study.

Authors:  Yuanxin Liang; Tao Zuo
Journal:  Head Neck Pathol       Date:  2016-10-21

5.  Cholesterol granuloma in thyroglossal cysts: a clinicopathological study.

Authors:  Itzhak Shvili; Tuvia Hadar; Rima Sadov; Rumelia Koren; Jacob Shvero
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-02-11       Impact factor: 2.503

6.  Papillary Thyroid Carcinoma as a Lateral Neck Cyst: A Cystic Metastatic Node versus an Ectopic Thyroid Tissue.

Authors:  Frhana Rahmat; Ananth Kumar Marutha Muthu; Navarasi S Raja Gopal; Soh Jo Han; Azura Sharena Yahaya
Journal:  Case Rep Endocrinol       Date:  2018-10-18

7.  Interstitial fibrosis in papillary thyroid microcarcinoma and its association with biological behavior.

Authors:  Xun Liu; Shuai Zhang; Qinwei Gang; Shikai Shen; Jian Zhang; Yu Lun; Dongdong Xu; Zhiquan Duan; Shijie Xin
Journal:  Oncol Lett       Date:  2018-02-02       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.